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ABSTRACT
Allergic rhinitis is a common comorbid condition in pediatric chronic rhinosinusitis (CRS). Testing for aeroallergen
sensitization should therefore be considered in the evaluation of children with CRS. At present the aeroallergen sensitivity
profile of children with CRS remains uncharacterized. In this study, we retrospectively identify a consecutive series of children
with CRS and allergic rhinitis who have undergone joint otolaryngology and allergy evaluation at a single tertiary care center.
We describe the aeroallergen sensitivity profiles (based upon formal skin testing) of these children, stratifying them according
to co-morbidity status: 1) CRS with cystic fibrosis (CF), 2) CRS with immune deficiency and 3) uncomplicated CRS (without
co-morbid CF, immune deficiency or primary ciliary dyskinesia). We identify 208 children (average age 9.3 years, standard
deviation 4.8 years) with CRS and allergic rhinitis meeting inclusion criteria, 140 with uncomplicated CRS, 64 with co-morbid
immune deficiency and 4 with co-morbid CF. The prevalence of indoor aeroallergen sensitivities (62.9–100.0%) was more
common than that of outdoor aeroallergen sensitivities (43.8–50.0%) in all three cohorts of children. In all three cohorts, the
most common indoor aeroallergen sensitivity was to dust mites (50.0–75.0%) and the most common outdoor aeroallergen
sensitivity was to tree pollens (43.8–50.0%). The aeroallergen sensitivity profile of children with CRS and allergic rhinitis
appears to be similar to that of the general pediatric population with allergic rhinitis, and parallels the aeroallergen sensitivities
previously described for adults with CRS and allergic rhinitis. Knowledge of the aeroallergen sensitivities in children with CRS
and allergic rhinitis will enhance both diagnostic and treatment strategies.
(Allergy Rhinol 5:e143–e145, 2014; doi: 10.2500/ar.2014.5.0102)
A
llergic rhinitis (AR) and chronic rhinosinusitis
(CRS) are both characterized clinically by sinonasal
inflammation and immunologically by shared inflamma-
tory mediators.
1 These conditions are commonly comor-
bid,
2,3 and a role for AR is suspected in the pathogenesis
and persistence of CRS.
4,5 The primary management of
pediatric CRS consists of medical treatment aimed, in
part, to reduce underlying sinonasal inflammation.
6 Be-
cause 27% of children with CRS are reported to have
concurrent AR,
3 knowledge of their aeroallergen sensi-
tivity profile is important to direct therapeutic manage-
ment strategies. However, the aeroallergen sensitivity
profile of children with CRS and AR has not been previ-
ously described. We describe here the aeroallergen sen-
sitivity profile of a consecutive series of 208 children, 18
years of age or younger, identified as having both CRS
and AR on joint otolaryngology and allergy evaluation.
These children comprise the subset of a previously de-
scribed pediatric CRS cohort with AR,
3 who also had
available results from formal allergy testing by skin-prick
and/or intradermal testing.
Approval for this study was obtained from the Boston
Children’s Hospital Institutional Review Board. Children
included in this study, and their diagnoses of interest,
were identified based on their associated International
Classification of Diseases, ninth revision codes for CRS
(473.*) as well as AR (477.*), asthma (493.*), immune
deficiencies (279.*), cystic fibrosis (CF) (277.*), and pri-
mary ciliary dyskinesia (PCD) (759.*). The clinical diag-
nosis of CRS in these children was made by a history of
90 days or more of upper airway and sinonasal symp-
toms, including but not limited to nasal obstruction, pu-
rulent rhinorrhea, and cough.
Children with CRS were considered to have “uncom-
plicated CRS” if they did not have a concurrent im-
mune deficiency, CF, or PCD.
3 Demographic data con-
sisting of age at the time of presentation and gender
were recorded. Formal allergy testing by skin-prick
testing to commercially available extracts (Greer Lab-
oratories, Lenoir, NC; Hollister-Stier, Spokane, WA)
was performed using standard methods and as previ-
ously reported.
5 Adjunct intradermal testing was used
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use of intradermal testing was limited only to specific
allergens suspected by clinical history that were nega-
tive by skin-prick testing. Aeroallergen sensitivities
were broadly categorized as mites, molds, grass, trees,
weeds, cockroach, mouse, cat, and dog. Mite allergy
was based on positive testing to Dermatophagoides ptero-
nyssinus allergen 1, Dermatophagoides farinae allergen 1,
or a house dust mix. Mold allergy was based on posi-
tive testing to Epicoccum, Alternaria, Hormodendrum,
Aspergillus, Penicillium, or Helminthosporium. Grass
allergy was tested using a grass mix (Kentucky blue,
orchard, red top, timothy, and sweet vernal grass).
Tree allergy was based on allergy to pollens from
extracts of birch, oak, elm, maple, red cedar, ash, hick-
ory, mulberry, cottonwood, or some mixture of these
extracts. Weed allergy was based on allergy to sage
brush, lamb’s quarter, marsh elder, yellow dock, plan-
tain, or ragweed. Cockroach, mouse, cat, and dog al-
lergies were based on positive testing to standard an-
tigens. Positive histamine and negative saline controls
were used in all cases. Wheal diameters were mea-
sured 15 minutes after the skin-prick or intradermal
test was placed. For both skin-prick and intradermal
testing, a wheal diameter at least three millimeters
larger than the negative control was considered posi-
tive. Medications that might interfere with test results
were withheld before skin testing (short-acting antihis-
tamines for 3 days, long-acting antihistamines for 10
days, and cetirizine for 14 days). Patients were ex-
cluded if they had a negative histamine control.
Our cohort of children with CRS and AR was 52% male
and 48% female with a mean age 9.3 years (standard
deviation of 4.8 years). Aeroallergen sensitivity profiles
were determined for children with uncomplicated CRS
(N  140) as well as for children with CRS who had
comorbid CF (N  4) or immune deficiencies (N  64).
Only one patient with CRS had PCD, due to the
paucity of data, was excluded from further charac-
terization of aeroallergen sensitivity profiles. Multi-
ple aeroallergen sensitizations were documented in
all CRS groups (Table 1).
Indoor aeroallergen (mites, cat, dog, cockroach, and
mouse) sensitivity was more common than outdoor
aeroallergen sensitivity. Indoor aeroallergen sensitivity
was found in 63% of children with uncomplicated CRS,
100% of children with CRS and CF, and 64% of children
with CRS and an immune deficiency. Sensitivity to dust
mites was the most prevalent indoor aeroallergen sensi-
tivity in all groups of children, although sensitivities to
molds, the dander of various animals, and cockroach
were also common. Overall, 71% of children with uncom-
plicated CRS and AR were found to be sensitive to pe-
rennial environmental aeroallergens, either mold or alter-
native indoor aeroallergens. Of children with AR and
CRS with concurrent immune deficiency, 73% had either
mold or indoor aeroallergen sensitivities.
Although less prevalent than indoor aeroallergen
sensitivity, outdoor aeroallergen sensitivity nonethe-
less affected a substantial proportion of children with
CRS. Outdoor aeroallergen sensitivities were found in
47% of children with uncomplicated CRS, 50% of chil-
dren with CRS and concurrent CF, and 44% of children
with CRS and concurrent immune deficiency. Of out-
door aeroallergens, sensitivity to tree pollens was most
common in all three cohorts.
CRS represents a heterogeneous set of disease pro-
cesses that phenotypically converge with respect to
chronic mucosal inflammation of the paranasal si-
nuses.
1 Previous work has described associations be-
tween comorbidities such as CF, immune deficiency
and PCD, and the pathogenesis of CRS. AR may also
contribute to the development or persistence of CRS
via mucosal inflammation of the sinonasal cavity
4,5
and is more common than CF, immune deficiency, or
PCD in children with CRS.
3 However, the aeroallergen
sensitivity profile of children with CRS and AR has not
been previously described.
The novel characterization of aeroallergen sensitivi-
ties in children with CRS and AR presented here re-
veals a high prevalence of sensitization to all major
categories of indoor and outdoor aeroallergens. This
study is limited by its retrospective nature and depen-
dence on International Classification of Diseases, ninth
revision codes for identifying patients. Our institu-
tion’s status as a pediatric tertiary care center likely
introduces a referral bias as well. These limitations
Table 1. Prevalence of allergen sensitivities in
children with CRS
Allergen Uncomplicated
CRS*
(N  140)
CRS and
CF (N  4)
CRS and
Immune
Deficiency
(N  64)
Molds 27.1% 50.0% 25.4%
Indoor 62.9% 100.0% 64.1%
Mites 51.4% 75.0% 50.0%
Cat 37.1% 50.0% 41.9%
Dog 23.6% 0.0% 22.3%
Cockroach 15.7% 25.0% 6.6%
Mouse 15.0% 0.0% 3.3%
Outdoor 47.1% 50% 43.8%
Trees 42.9% 50% 41.0%
Grass 17.1% 0.0% 13.1%
Weeds 25.0% 25% 24.6%
*  Without cystic fibrosis, immune deficiency, and primary
ciliary dyskinesia; CRS  chronic rhinosinusitis; CF 
cystic fibrosis.
e144 Fall 2014, Vol. 5, No. 3aside, the aeroallergen sensitivity profile of children
with CRS was found to be similar to that previously
reported for atopic children overall, with indoor
aeroallergen sensitivities more common than outdoor
aeroallergen sensitivities.
7 Moreover, in all cohorts of
children, dust mites represent the most common in-
door aeroallergen sensitivity, and trees represent the
most common outdoor aeroallergen sensitivity. These
findings are also consistent with the aeroallergen sen-
sitivity profile previously reported for the adult CRS
population.
8 The predominance of indoor aeroallergen
sensitivities supports a role for persistent AR-driven
sinonasal inflammation as an important contributor to
the pathophysiology of CRS in atopic children.
In addition to impaired quality of life,
9 CRS can also
place children at increased risk for other more worri-
some sinusitis sequelae such as orbital and intracranial
complications.
10 Efforts should therefore be made to
identify additional sources of sinonasal inflammation
in children with CRS. Previous work has demonstrated
the prevalence of AR in children with CRS to be greater
than the combined prevalence of the more commonly
sought comorbid conditions of CF, immune deficiency,
and PCD.
3 Knowledge of the likely triggers for allergic
sinonasal inflammation in children with concurrent AR
and CRS is of clinical utility in reducing the disease
burden of chronic sinonasal inflammation in such pa-
tients.
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